ArticleNPJ breast cancer2025
Racial and ethnic disparities in survival outcomes among patients with inflammatory breast cancer: a systematic review and meta-analysis.
Article in NPJ breast cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Population-Associated Molecular Variation in Histologically Normal Breast Tissue Is Associated with Distinct Baseline Transcriptional States.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Inflammatory breast cancer (IBC) is a rare and aggressive subtype of breast cancer characterized by rapid progression, early metastasis, and poor prognosis. While racial and ethnic disparities in IBC outcomes have been reported, existing findings remain inconsistent. We conducted the first systematic review and meta-analysis to comprehensively evaluate survival disparities by race and ethnicity among patients with IBC. A systematic search of MEDLINE and EMBASE identified 15 eligible studies. Compared to non-Hispanic White (NHW) patients, non-Hispanic Black patients had higher mortality (HR: 1.45; 95% CI: 1.34-1.57), while Asian or Asian Pacific Islander (API) patients had lower mortality (HR: 0.78; 95% CI: 0.65-0.94). Hispanic patients did not show statistically different survival outcomes compared to NHW patients (HR: 1.06, 95% CI 0.88-1.28). These findings underscore persistent racial disparities in IBC outcomes, although inherent biases and confounding in observational studies warrant cautious interpretation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.